Conjugated linoleic acid or CLA is a fairly new supplement on the market which was spurred by some very surprising research results conducted on women with breast cancer. Because it is so new, the research as you'll find below, both supports and opposes its use as a fat burner.
Research Title: Safety profile of conjugated linoleic acid in a 12-month trial in obese humans.
Year Published: 2004
Research Summary: Researchers evaluated a linoleic acid supplement called Clarinol over 12 months with obese humans. Participants were given 6 g of conjugated linoleic acid or a placebo. Over the 12 months subjects filled out questionaires asking about side effects and adverse effects at bi-weekly visits. Blood tests were also done to assess liver function, glucose, insulin, serum lipids, blood counts, and general chemistry. No differences were found between the treatment and placebo groups in body fat composition, however, the Clarinol was found to be safe for human composition over a year.
Research Title: Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance.
Year Published: 2002
Research Summary: 60 obese men with metabolic syndrome (the Mayo Clinic defines this as a cluster of warning signs such as high blood pressure, high insulin levels, excess body weight and high cholesterol2) were either given a CLA isomer, a CLA mixture or a placebo over three months to find out what effects conjugated linoleic acid had on insulin resistance, oxidative stress and inflammatory disease.
Researchers reported that the group that received the conjugated linoleic acid isomer were found to have increased oxidative stress and inflammatory biomarkers, which they feel may be linked to induced insulin resistance. The authors indicated that this might be of clinical relevance with respect to cardiovascular disease.
Research Title: Supplemental products used for weight loss.
Year Published: 2004
Research Summary: A review was undertaken of several well known weight loss supplements on the market. One being conjugated linoleic acid, which was found to have favourable effects on weight loss in three clinical trials, with few adverse effects. The author notes that more research needs to be conducted into these supplements for safety data.
Research Title: The effect of six different C18 fatty acids on body fat and energy metabolism in mice.
Year Published: 2004
Research Summary: Mice were fed either of five diets with caprylic, capric, lauric, and myristic fatty acids and compared to mice fed a diet with 4% CLA over 35 days. The mice receiving the CLA made improvements in body fat as opposed to no significant effects in mice receiving non-CLA fatty acids.
The study found that the group receiving CLA had the lowest rate of storage of energy intake and that they expended the highest percentage of energy intake as heat as compared to those who received a non-CLA supplement.
The research also found that the group receiving the CLA had the highest levels of energy and fat intake amongst the six groups.
Conjugated Linoleic Acid is an altered form of linoleic acid, which is a fatty acid that your body can't manufacture but needs for good health. If linoleic acid is excluded from the diet, retarded growth and skin lesions have been seen to occur in animals. Because of this need for this fatty acid, but the body's inability to manufacture it, it is termed an "essential fatty acid".1
While some research does suggest that this supplement is useful for weight loss, it is very new to the market.
At this point, a 6 g daily dose of conjugated linoleic acid has been shown to be safe for obese individuals. Some studies indicate that diets high in omega 6 fatty acids which include linoleic acid, have heightened prevalence of insulin resistance, and cardiovascular disease.
Foods that are high in linoleic acid include, beef, lamb and whole milk.
Other references you might be interested in:
1. Barasi, M. (1997) Human Nutrition Oxford University Press P. 79